Metabolic regulators. Pyruvate dehydrogenase kinase 4 (PDK4), a gatekeeper of TCA cycle, is downregulated in MEKi resistant NSCLC cells 187, yet the role of metabolic regulators in driving KRAS targeted therapy resistance are still under exploited. Here, PDK4 is linked to non-small cell lung carcinoma.